{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T14:36:21Z","timestamp":1723646181220},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00399-019-00637-y","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T12:03:12Z","timestamp":1566475392000},"page":"234-239","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Herzrhythmusst\u00f6rungen bei Patienten mit pulmonaler Hypertonie und Lungenerkrankungen"],"prefix":"10.1007","volume":"30","author":[{"given":"Dirk","family":"Bandorski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"H\u00f6ltgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardeschir","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"issue":"10","key":"637_CR1","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib\u00a0SM, Stevenson\u00a0WG, Ackerman\u00a0MJ et al (2018) 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart rhythm society. Heart Rhythm 15(10):e190\u2013e252. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2017.10.035","journal-title":"Heart Rhythm"},{"issue":"4","key":"637_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.5603\/CJ.a2016.0044","volume":"23","author":"D Bandorski","year":"2016","unstructured":"Bandorski\u00a0D, Bogossian\u00a0H, Ecke\u00a0A et\u00a0al (2016) Evaluation of the prognostic value of electrocardiography parameters and heart rhythm in patients with pulmonary hypertension. Cardiol\u00a0J 23(4):465\u2013472. \n                    https:\/\/doi.org\/10.5603\/CJ.a2016.0044","journal-title":"Cardiol J"},{"key":"637_CR3","doi-asserted-by":"publisher","first-page":"1327265","DOI":"10.1155\/2016\/1327265","volume":"2016","author":"D Bandorski","year":"2016","unstructured":"Bandorski\u00a0D, Bogossian\u00a0H, Stempfl\u00a0J et\u00a0al (2016) Prognostic relevance of Nonsustained ventricular tachycardia in patients with pulmonary hypertension. Biomed Res Int 2016:1327265. \n                    https:\/\/doi.org\/10.1155\/2016\/1327265","journal-title":"Biomed Res Int"},{"issue":"2","key":"637_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00399-015-0364-8","volume":"26","author":"D Bandorski","year":"2015","unstructured":"Bandorski\u00a0D, Erkapic\u00a0D, Stempfl\u00a0J et\u00a0al (2015) Ventricular tachycardias in patients with pulmonary hypertension: an underestimated prevalence? A prospective clinical study. Herzschrittmachertherapie Elektrophysiologie 26(2):155\u2013162. \n                    https:\/\/doi.org\/10.1007\/s00399-015-0364-8","journal-title":"Herzschrittmachertherapie Elektrophysiologie"},{"key":"637_CR5","doi-asserted-by":"publisher","first-page":"617565","DOI":"10.1155\/2014\/617565","volume":"2014","author":"D Bandorski","year":"2014","unstructured":"Bandorski\u00a0D, Schmitt\u00a0J, Kurzlechner\u00a0C et\u00a0al (2014) Electrophysiological studies in patients with pulmonary hypertension: a\u00a0retrospective investigation. Biomed Res Int 2014:617565. \n                    https:\/\/doi.org\/10.1155\/2014\/617565","journal-title":"Biomed Res Int"},{"issue":"3","key":"637_CR6","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1378\/chest.08-0492","volume":"135","author":"HJ Bogaard","year":"2009","unstructured":"Bogaard\u00a0HJ, Abe\u00a0K, Vonk Noordegraaf\u00a0A et al (2009) The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 135(3):794\u2013804. \n                    https:\/\/doi.org\/10.1378\/chest.08-0492","journal-title":"Chest"},{"issue":"3","key":"637_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1172\/JCI115659","volume":"89","author":"MR Bristow","year":"1992","unstructured":"Bristow\u00a0MR, Minobe\u00a0W, Rasmussen\u00a0R et al (1992) Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J\u00a0Clin Invest 89(3):803\u2013815. \n                    https:\/\/doi.org\/10.1172\/JCI115659","journal-title":"J Clin Invest"},{"issue":"3","key":"637_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/ehjcvp\/pvv019","volume":"1","author":"G Campo","year":"2015","unstructured":"Campo\u00a0G, Pavasini\u00a0R, Biscaglia\u00a0S et\u00a0al (2015) Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease. Eur Heart Journal Cardiovasc Pharmacother 1(3):205\u2013211. \n                    https:\/\/doi.org\/10.1093\/ehjcvp\/pvv019","journal-title":"Eur Heart Journal Cardiovasc Pharmacother"},{"issue":"12","key":"637_CR9","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.amjcard.2015.09.039","volume":"116","author":"M Cannillo","year":"2015","unstructured":"Cannillo\u00a0M, Grosso Marra\u00a0W, Gili\u00a0S et\u00a0al (2015) Supraventricular arrhythmias in patients with pulmonary arterial hypertension. Am J Cardiol 116(12):1883\u20131889. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2015.09.039","journal-title":"Am J Cardiol"},{"issue":"1","key":"637_CR10","doi-asserted-by":"publisher","first-page":"204589401983489","DOI":"10.1177\/2045894019834890","volume":"9","author":"MM Cirulis","year":"2019","unstructured":"Cirulis\u00a0MM, Ryan\u00a0JJ, Archer\u00a0SL (2019) Pathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Pulm Circ 9(1):2045894019834890. \n                    https:\/\/doi.org\/10.1177\/2045894019834890","journal-title":"Pulm Circ"},{"issue":"7","key":"637_CR11","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4187\/respcare.02252","volume":"58","author":"EA Demerouti","year":"2013","unstructured":"Demerouti\u00a0EA, Manginas\u00a0AN, Athanassopoulos\u00a0GD et\u00a0al (2013) Complications leading to sudden cardiac death in pulmonary arterial hypertension. Respir Care 58(7):1246\u20131254. \n                    https:\/\/doi.org\/10.4187\/respcare.02252","journal-title":"Respir Care"},{"issue":"2","key":"637_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejheart.2003.09.007","volume":"6","author":"L Fauchier","year":"2004","unstructured":"Fauchier\u00a0L, Babuty\u00a0D, Melin\u00a0A et\u00a0al (2004) Heart rate variability in severe right or left heart failure: the role of pulmonary hypertension and resistances. Eur J Heart Fail 6(2):181\u2013185. \n                    https:\/\/doi.org\/10.1016\/j.ejheart.2003.09.007","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"637_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00408-003-1034-x","volume":"181","author":"AF Folino","year":"2003","unstructured":"Folino\u00a0AF, Bobbo\u00a0F, Schiraldi\u00a0C et\u00a0al (2003) Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension. Am J Physiol 181(6):321\u2013328. \n                    https:\/\/doi.org\/10.1007\/s00408-003-1034-x","journal-title":"Am J Physiol"},{"issue":"1","key":"637_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8\u00a0N, Humbert\u00a0M, Vachiery\u00a0J\u2011L et al (2016) 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): endorsed by: association for European Paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur Heart\u00a0J 37(1):67\u2013119. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehv317","journal-title":"Eur Heart J"},{"key":"637_CR15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02148-2018","author":"N Gali\u00e8","year":"2019","unstructured":"Gali\u00e8\u00a0N, McLaughlin\u00a0VV, Rubin\u00a0LJ et\u00a0al (2019) An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir\u00a0J. \n                    https:\/\/doi.org\/10.1183\/13993003.02148-2018","journal-title":"Eur Respir J"},{"issue":"23","key":"637_CR16","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1016\/j.jacc.2017.03.597","volume":"69","author":"N Gali\u00e8","year":"2017","unstructured":"Gali\u00e8\u00a0N, Saia\u00a0F, Palazzini\u00a0M et\u00a0al (2017) Left main coronary artery compression in patients with pulmonary arterial hypertension and angina. J\u00a0Am Coll Cardiol 69(23):2808\u20132817. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2017.03.597","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"637_CR17","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jjcc.2016.12.013","volume":"69","author":"CA Goudis","year":"2017","unstructured":"Goudis\u00a0CA (2017) Chronic obstructive pulmonary disease and atrial fibrillation: an unknown relationship. J\u00a0Cardiol 69(5):699\u2013705. \n                    https:\/\/doi.org\/10.1016\/j.jjcc.2016.12.013","journal-title":"J Cardiol"},{"key":"637_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijcard.2018.08.085","volume":"272","author":"E Gr\u00fcnig","year":"2018","unstructured":"Gr\u00fcnig\u00a0E, Benjamin\u00a0N, Kr\u00fcger\u00a0U et\u00a0al (2018) General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol 272:30\u201336. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.085","journal-title":"Int J Cardiol"},{"issue":"12","key":"637_CR19","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/europace\/eur189","volume":"13","author":"M Hardziyenka","year":"2011","unstructured":"Hardziyenka\u00a0M, Surie\u00a0S, de Groot\u00a0JR et al (2011) Right ventricular pacing improves haemodynamics in right ventricular failure from pressure overload: an open observational proof-of-principle study in patients with chronic thromboembolic pulmonary hypertension. Europace 13(12):1753\u20131759. \n                    https:\/\/doi.org\/10.1093\/europace\/eur189","journal-title":"Europace"},{"issue":"3","key":"637_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1164\/ajrccm.165.3.200109-0130c","volume":"165","author":"MM Hoeper","year":"2002","unstructured":"Hoeper\u00a0MM, Gali\u00e9\u00a0N, Murali\u00a0S et\u00a0al (2002) Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 165(3):341\u2013344. \n                    https:\/\/doi.org\/10.1164\/ajrccm.165.3.200109-0130c","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"637_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3238\/arztebl.2017.0073","volume":"114","author":"MM Hoeper","year":"2017","unstructured":"Hoeper\u00a0MM, Ghofrani\u00a0H\u2011A, Gr\u00fcnig\u00a0E et al (2017) Pulmonary hypertension. Dtsch Arztebl Int 114(5):73\u201384. \n                    https:\/\/doi.org\/10.3238\/arztebl.2017.0073","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"637_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","volume":"4","author":"MM Hoeper","year":"2016","unstructured":"Hoeper\u00a0MM, Humbert\u00a0M, Souza\u00a0R et\u00a0al (2016) A global view of pulmonary hypertension. Lancet Respir Med 4(4):306\u2013322. \n                    https:\/\/doi.org\/10.1016\/S2213-2600(15)00543-3","journal-title":"Lancet Respir Med"},{"key":"637_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ijcard.2015.11.001","volume":"203","author":"MM Hoeper","year":"2016","unstructured":"Hoeper\u00a0MM, Huscher\u00a0D, Pittrow\u00a0D (2016) Incidence and prevalence of pulmonary arterial hypertension in Germany. Int J Cardiol 203:612\u2013613. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2015.11.001","journal-title":"Int J Cardiol"},{"issue":"1","key":"637_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10840-014-9928-5","volume":"41","author":"A Kanmanthareddy","year":"2014","unstructured":"Kanmanthareddy\u00a0A, Reddy\u00a0YM, Boolani\u00a0H et\u00a0al (2014) Incidence, predictors, and clinical course of atrial tachyarrhythmias in patients with pulmonary hypertension. J\u00a0Interv Card Electrophysiol 41(1):9\u201314. \n                    https:\/\/doi.org\/10.1007\/s10840-014-9928-5","journal-title":"J Interv Card Electrophysiol"},{"issue":"6","key":"637_CR25","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.hrthm.2017.09.042","volume":"15","author":"T Konecny","year":"2018","unstructured":"Konecny\u00a0T, Somers\u00a0KR, Park\u00a0JY et\u00a0al (2018) Chronic obstructive pulmonary disease as a\u00a0risk factor for ventricular arrhythmias independent of left ventricular function. Heart Rhythm 15(6):832\u2013838. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2017.09.042","journal-title":"Heart Rhythm"},{"key":"637_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fped.2015.00063","volume":"3","author":"H Latus","year":"2015","unstructured":"Latus\u00a0H, Bandorski\u00a0D, Rink\u00a0F et\u00a0al (2015) Heart rate variability is related to disease severity in children and young adults with pulmonary hypertension. Front Pediatr 3:63. \n                    https:\/\/doi.org\/10.3389\/fped.2015.00063","journal-title":"Front Pediatr"},{"issue":"1","key":"637_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5115\/acb.2016.49.1.7","volume":"49","author":"JC Lee","year":"2016","unstructured":"Lee\u00a0JC, Kim\u00a0KC, Choe\u00a0SY et al (2016) Reduced immunoreactivities of B\u2011type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatment. Anat Cell Biol 49(1):7\u201314. \n                    https:\/\/doi.org\/10.5115\/acb.2016.49.1.7","journal-title":"Anat Cell Biol"},{"issue":"11","key":"637_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.hlc.2012.06.005","volume":"21","author":"U Luesebrink","year":"2012","unstructured":"Luesebrink\u00a0U, Fischer\u00a0D, Gezgin\u00a0F et\u00a0al (2012) Ablation of typical right atrial flutter in patients with pulmonary hypertension. Heart Lung Circ 21(11):695\u2013699. \n                    https:\/\/doi.org\/10.1016\/j.hlc.2012.06.005","journal-title":"Heart Lung Circ"},{"issue":"5","key":"637_CR29","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.hlc.2015.10.008","volume":"25","author":"K Ma\u0142aczy\u0144ska-Rajpold","year":"2016","unstructured":"Ma\u0142aczy\u0144ska-Rajpold\u00a0K, Komosa\u00a0A, B\u0142aszyk\u00a0K et al (2016) The management of Supraventricular Tachyarrhythmias in patients with pulmonary arterial hypertension. Heart Lung Circ 25(5):442\u2013450. \n                    https:\/\/doi.org\/10.1016\/j.hlc.2015.10.008","journal-title":"Heart Lung Circ"},{"issue":"2","key":"637_CR30","doi-asserted-by":"publisher","first-page":"204589401876987","DOI":"10.1177\/2045894018769874","volume":"8","author":"V Mercurio","year":"2018","unstructured":"Mercurio\u00a0V, Peloquin\u00a0G, Bourji\u00a0KI et\u00a0al (2018) Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact. Pulm Circ 8(2):2045894018769874. \n                    https:\/\/doi.org\/10.1177\/2045894018769874","journal-title":"Pulm Circ"},{"key":"637_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijcard.2018.08.081","volume":"272","author":"KM Olsson","year":"2018","unstructured":"Olsson\u00a0KM, Halank\u00a0M, Egenlauf\u00a0B et\u00a0al (2018) Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: updated recommendations from the cologne consensus conference 2018. Int J Cardiol 272:46\u201352. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.081","journal-title":"Int J Cardiol"},{"issue":"5","key":"637_CR32","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.ijcard.2012.06.024","volume":"167","author":"KM Olsson","year":"2013","unstructured":"Olsson\u00a0KM, Nickel\u00a0NP, Tongers\u00a0J et\u00a0al (2013) Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol 167(5):2300\u20132305. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2012.06.024","journal-title":"Int J Cardiol"},{"issue":"1","key":"637_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00109-009-0524-6","volume":"88","author":"L Piao","year":"2010","unstructured":"Piao\u00a0L, Fang\u00a0Y\u2011H, Cadete\u00a0VJJ et al (2010) The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J\u00a0Mol Med 88(1):47\u201360. \n                    https:\/\/doi.org\/10.1007\/s00109-009-0524-6","journal-title":"J Mol Med"},{"issue":"7","key":"637_CR34","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0735-1097(02)01744-8","volume":"39","author":"RJ Raymond","year":"2002","unstructured":"Raymond\u00a0RJ, Hinderliter\u00a0AL, Willis\u00a0PW et\u00a0al (2002) Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J\u00a0Am Coll Cardiol 39(7):1214\u20131219. \n                    https:\/\/doi.org\/10.1016\/S0735-1097(02)01744-8","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"637_CR35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1161\/CIRCEP.110.960435","volume":"4","author":"S-Y Roh","year":"2011","unstructured":"Roh\u00a0S\u2011Y, Choi\u00a0J\u2011I, Lee\u00a0JY et al (2011) Catheter ablation of atrial fibrillation in patients with chronic lung disease. Circ Arrhythm Electrophysiol 4(6):815\u2013822. \n                    https:\/\/doi.org\/10.1161\/CIRCEP.110.960435","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"637_CR36","doi-asserted-by":"publisher","first-page":"e33902","DOI":"10.1371\/journal.pone.0033902","volume":"7","author":"D Rottlaender","year":"2012","unstructured":"Rottlaender\u00a0D, Motloch\u00a0LJ, Schmidt\u00a0D et\u00a0al (2012) Clinical impact of atrial fibrillation in patients with pulmonary hypertension. PLoS ONE 7(3):e33902. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0033902","journal-title":"PLoS ONE"},{"issue":"1","key":"637_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijcard.2010.09.065","volume":"146","author":"MJ Ruiz-Cano","year":"2011","unstructured":"Ruiz-Cano\u00a0MJ, Gonzalez-Mansilla\u00a0A, Escribano\u00a0P et al (2011) Clinical implications of supraventricular arrhythmias in patients with severe pulmonary arterial hypertension. Int J Cardiol 146(1):105\u2013106. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2010.09.065","journal-title":"Int J Cardiol"},{"issue":"5","key":"637_CR38","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2215\/CJN.01960408","volume":"3","author":"RW Schrier","year":"2008","unstructured":"Schrier\u00a0RW, Bansal\u00a0S (2008) Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol 3(5):1232\u20131237. \n                    https:\/\/doi.org\/10.2215\/CJN.01960408","journal-title":"Clin J Am Soc Nephrol"},{"key":"637_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.003020","author":"KC Siontis","year":"2015","unstructured":"Siontis\u00a0KC, Geske\u00a0JB, Gersh\u00a0BJ (2015) Atrial fibrillation pathophysiology and prognosis: insights from cardiovascular imaging. Circ Cardiovasc Imaging. \n                    https:\/\/doi.org\/10.1161\/CIRCIMAGING.115.003020","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"637_CR40","doi-asserted-by":"publisher","first-page":"204589401879031","DOI":"10.1177\/2045894018790316","volume":"8","author":"B Smith","year":"2018","unstructured":"Smith\u00a0B, Genuardi\u00a0MV, Koczo\u00a0A et\u00a0al (2018) Atrial arrhythmias are associated with increased mortality in pulmonary arterial hypertension. Pulm Circ 8(3):2045894018790316. \n                    https:\/\/doi.org\/10.1177\/2045894018790316","journal-title":"Pulm Circ"},{"issue":"1","key":"637_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jcpt.12767","volume":"44","author":"CD Thomas","year":"2019","unstructured":"Thomas\u00a0CD, Dupree\u00a0LH, DeLosSantos\u00a0M et al (2019) Evaluation of the protective effects of \u03b2\u2011blockers in the management of acute exacerbations of chronic obstructive pulmonary disease. J\u00a0Clin Pharm Ther 44(1):109\u2013114. \n                    https:\/\/doi.org\/10.1111\/jcpt.12767","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"637_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ahj.2006.09.008","volume":"153","author":"J Tongers","year":"2007","unstructured":"Tongers\u00a0J, Schwerdtfeger\u00a0B, Klein\u00a0G et\u00a0al (2007) Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart\u00a0J 153(1):127\u2013132. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2006.09.008","journal-title":"Am Heart J"},{"issue":"7","key":"637_CR43","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1161\/01.CIR.0000084544.54513.E2","volume":"108","author":"A Torbicki","year":"2003","unstructured":"Torbicki\u00a0A, Kurzyna\u00a0M, Kuca\u00a0P et\u00a0al (2003) Detectable serum cardiac troponin T as a\u00a0marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 108(7):844\u2013848. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000084544.54513.E2","journal-title":"Circulation"},{"issue":"1","key":"637_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/eurheartj\/ehm567","volume":"29","author":"SA van Wolferen","year":"2008","unstructured":"van Wolferen\u00a0SA, Marcus\u00a0JT, Westerhof\u00a0N et\u00a0al (2008) Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart\u00a0J 29(1):120\u2013127. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehm567","journal-title":"Eur Heart J"},{"issue":"3","key":"637_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.hrtlng.2018.01.004","volume":"47","author":"M Walig\u00f3ra","year":"2018","unstructured":"Walig\u00f3ra\u00a0M, Tyrka\u00a0A, Miszalski-Jamka\u00a0T et al (2018) Right atrium enlargement predicts clinically significant supraventricular arrhythmia in patients with pulmonary arterial hypertension. Heart Lung 47(3):237\u2013242. \n                    https:\/\/doi.org\/10.1016\/j.hrtlng.2018.01.004","journal-title":"Heart Lung"},{"issue":"9","key":"637_CR46","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.amjcard.2014.07.079","volume":"114","author":"L Wen","year":"2014","unstructured":"Wen\u00a0L, Sun\u00a0M\u2011L, An\u00a0P et al (2014) Frequency of supraventricular arrhythmias in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol 114(9):1420\u20131425. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2014.07.079","journal-title":"Am J Cardiol"},{"issue":"17","key":"637_CR47","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/eurheartj\/ehl199","volume":"27","author":"DP Zipes","year":"2006","unstructured":"Zipes\u00a0DP, Camm\u00a0AJ, Borggrefe\u00a0M et\u00a0al (2006) ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death\u2014executive summary: a report of the American college of cardiology\/American heart association task force and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European heart rhythm association and the heart rhythm society. Eur Heart\u00a0J 27(17):2099\u20132140. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehl199","journal-title":"Eur Heart J"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-019-00637-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00399-019-00637-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-019-00637-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:34:49Z","timestamp":1597966489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00399-019-00637-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["637"],"URL":"https:\/\/doi.org\/10.1007\/s00399-019-00637-y","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"28 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Bandorski, R.\u00a0H\u00f6ltgen, A.\u00a0Ghofrani, V.\u00a0Johnson und J.\u00a0Schmitt geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}